EE200000211A - Rasestumise vältimise meetod ja rasestumisvastase vahendi komplekt - Google Patents

Rasestumise vältimise meetod ja rasestumisvastase vahendi komplekt

Info

Publication number
EE200000211A
EE200000211A EEP200000211A EEP200000211A EE200000211A EE 200000211 A EE200000211 A EE 200000211A EE P200000211 A EEP200000211 A EE P200000211A EE P200000211 A EEP200000211 A EE P200000211A EE 200000211 A EE200000211 A EE 200000211A
Authority
EE
Estonia
Prior art keywords
contraception
contraceptive kit
contraceptive
kit
Prior art date
Application number
EEP200000211A
Other languages
English (en)
Inventor
Jay Gast Michael
Paul Miller Christopher
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of EE200000211A publication Critical patent/EE200000211A/et
Publication of EE04092B1 publication Critical patent/EE04092B1/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200000211A 1997-11-06 1998-11-04 Rasestumisvastase vahendi komplekt EE04092B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96508397A 1997-11-06 1997-11-06
PCT/US1998/023427 WO1999024027A2 (en) 1997-11-06 1998-11-04 Anti-estrogen plus progestin containing oral contraceptives

Publications (2)

Publication Number Publication Date
EE200000211A true EE200000211A (et) 2001-04-16
EE04092B1 EE04092B1 (et) 2003-08-15

Family

ID=25509417

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000211A EE04092B1 (et) 1997-11-06 1998-11-04 Rasestumisvastase vahendi komplekt

Country Status (28)

Country Link
EP (1) EP1051179B1 (et)
JP (1) JP2001522798A (et)
CN (1) CN1278732A (et)
AR (1) AR016667A1 (et)
AT (1) ATE304359T1 (et)
AU (2) AU760540B2 (et)
BG (1) BG104451A (et)
BR (1) BR9813982A (et)
CA (1) CA2307210A1 (et)
CZ (1) CZ294155B6 (et)
DE (1) DE69831605T2 (et)
DK (1) DK1051179T3 (et)
EA (1) EA200000492A1 (et)
EE (1) EE04092B1 (et)
ES (1) ES2246541T3 (et)
GE (1) GEP20043290B (et)
HR (1) HRP20000269A2 (et)
HU (1) HUP0100293A3 (et)
ID (1) ID24568A (et)
IL (1) IL135621A0 (et)
NO (1) NO20002167L (et)
NZ (1) NZ503890A (et)
PL (1) PL340623A1 (et)
SK (1) SK6482000A3 (et)
TR (1) TR200001268T2 (et)
UA (1) UA68365C2 (et)
WO (1) WO1999024027A2 (et)
ZA (1) ZA9810136B (et)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
EA005932B1 (ru) * 1998-05-15 2005-08-25 Уайт 2-фенил-1-[4-(2-аминоэтокси)бензил]индол в комбинации с эстрогенами
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
CA2382683A1 (en) * 1999-09-13 2001-03-22 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-¬4-(2-amin-1-yl-ethoxy)-benzyl|-1h-indol-5-ols
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
JP2005504032A (ja) 2001-07-31 2005-02-10 ファイザー・プロダクツ・インク エストロゲン・アゴニスト/アンタゴニスト、エストロゲン及びプロゲスチンの組み合わせを含む医薬組成物、キット及び方法
SI1809602T1 (sl) 2004-10-27 2009-04-30 Janssen Pharmaceutica Nv Indolni derivati, uporabni kot modulatorji progesteronskega receptorja
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
UY29527A1 (es) 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
DE102008057230A1 (de) * 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
RS56042B1 (sr) 2010-06-10 2017-09-29 Seragon Pharmaceuticals Inc Modulatori estrogenih receptora i njihove upotrebe
WO2013090829A1 (en) 2011-12-14 2013-06-20 Aragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
KR20240142622A (ko) 2015-10-01 2024-09-30 올레마 파마슈티컬스 인코포레이티드 테트라히드로-1H-피리도[3,4-b]인돌 항에스트로겐 약물
LT3386500T (lt) 2015-12-09 2022-12-27 The Board Of Trustees Of The University Of Illinois Selektyvūs estrogenų receptorių slopintojai benzotiofeno pagrindu
ES2990061T3 (es) 2016-05-10 2024-11-28 C4 Therapeutics Inc Degronímeros espirocíclicos para la degradación de proteínas diana
CN109641874A (zh) 2016-05-10 2019-04-16 C4医药公司 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
EP3454856B1 (en) 2016-05-10 2024-09-11 C4 Therapeutics, Inc. Heterocyclic degronimers for target protein degradation
CN109790143A (zh) 2016-05-10 2019-05-21 C4医药公司 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
RU2019102647A (ru) 2016-07-01 2020-08-03 Г1 Терапьютикс, Инк. Антипролиферационные средства на основе пиримидина
WO2018081168A2 (en) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
MX2019008158A (es) 2017-01-06 2019-12-09 G1 Therapeutics Inc Terapia de combinacion para el tratamiento del cancer.
KR20190117582A (ko) 2017-02-10 2019-10-16 쥐원 쎄라퓨틱스, 인크. 벤조티오펜 에스트로겐 수용체 조정제
CN110769822A (zh) 2017-06-20 2020-02-07 C4医药公司 用于蛋白降解的n/o-连接的降解决定子和降解决定子体
WO2019006393A1 (en) 2017-06-29 2019-01-03 G1 Therapeutics, Inc. Morphic forms of git38 and methods of manufacture thereof
CN120698983A (zh) 2018-12-20 2025-09-26 C4医药公司 靶向蛋白降解
KR20220034129A (ko) 2019-07-07 2022-03-17 올레마 파마슈티컬스 인코포레이티드 에스트로겐 수용체 길항제 요법
KR20220119415A (ko) 2019-12-20 2022-08-29 씨4 테라퓨틱스, 인코포레이티드 Egfr 분해를 위한 이소인돌리논 및 인다졸 화합물
TW202146412A (zh) 2020-03-05 2021-12-16 美商C4醫藥公司 用於標靶降解brd9之化合物
IL300397A (en) 2020-08-05 2023-04-01 C4 Therapeutics Inc Compounds for targeted knockdown of RET
MX2023014059A (es) 2021-06-08 2024-03-12 C4 Therapeutics Inc Terapeuticos para la degradacion de una proteina quiinasa de serina/ treonina mutante.
WO2024030968A1 (en) 2022-08-03 2024-02-08 Brystol-Myers Squibb Company Compounds for modulating ret protein
EP4611901A1 (en) 2022-11-04 2025-09-10 Bristol-Myers Squibb Company Ret-ldd protein degraders
WO2024097980A1 (en) 2022-11-04 2024-05-10 Bristol-Myers Squibb Company Ret-ldd protein inhibitors
EP4735452A2 (en) 2023-06-30 2026-05-06 Merck Patent GmbH Heterobifunctional compounds for the degradation of kras protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA716118B (en) * 1970-10-05 1972-05-31 Richardson Merrell Inc Contraception
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
IL120266A (en) * 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
PT802183E (pt) * 1996-04-19 2002-03-28 American Home Prod Agentes estrogenicos
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive

Also Published As

Publication number Publication date
CZ294155B6 (cs) 2004-10-13
NZ503890A (en) 2002-08-28
CN1278732A (zh) 2001-01-03
SK6482000A3 (en) 2000-11-07
AU760540B2 (en) 2003-05-15
DK1051179T3 (da) 2005-10-31
WO1999024027A2 (en) 1999-05-20
WO1999024027A3 (en) 1999-07-15
ES2246541T3 (es) 2006-02-16
ID24568A (id) 2000-07-27
EA200000492A1 (ru) 2000-10-30
GEP20043290B (en) 2004-07-26
EP1051179A2 (en) 2000-11-15
HRP20000269A2 (en) 2000-12-31
AR016667A1 (es) 2001-07-25
ATE304359T1 (de) 2005-09-15
IL135621A0 (en) 2001-05-20
AU1303199A (en) 1999-05-31
AU2003204896B2 (en) 2006-06-15
DE69831605T2 (de) 2006-06-14
EE04092B1 (et) 2003-08-15
HUP0100293A3 (en) 2002-12-28
JP2001522798A (ja) 2001-11-20
ZA9810136B (en) 2000-05-05
NO20002167L (no) 2000-06-28
HUP0100293A2 (hu) 2001-10-28
BG104451A (en) 2000-12-29
TR200001268T2 (tr) 2001-01-22
EP1051179B1 (en) 2005-09-14
DE69831605D1 (de) 2005-10-20
CA2307210A1 (en) 1999-05-20
UA68365C2 (en) 2004-08-16
BR9813982A (pt) 2000-09-26
NO20002167D0 (no) 2000-04-27
PL340623A1 (en) 2001-02-12
CZ20001661A3 (cs) 2000-12-13

Similar Documents

Publication Publication Date Title
EE200000211A (et) Rasestumise vältimise meetod ja rasestumisvastase vahendi komplekt
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
EE9600194A (et) Isekleepuv mark ja meetod selle valmistamiseks
NO975759D0 (no) Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel
FI973750A7 (fi) 2-metyylitienobentsodiatsepiinin valmistus ja kiteiset muodot
DK1041879T3 (da) Desinfektionsmiddel og fremstillingsmetode
NO972125D0 (no) Hemmoroideblandinger og fremgangsmåte for anvendelse
ID27859A (id) Tampon dan metoda pembuatannya
NO993288D0 (no) Antimikrobiell handske og fremgangsmÕte for fremstilling derav
FI980246A0 (fi) Menetelmä keittimen käyttämiseksi ja keitin
DK1334725T3 (da) Östroprogestativt antikonceptionsmiddel
PT826679E (pt) Compostos de naftilo intermediarios composicoes e metodos de utilizacao
FI955639L (fi) Kohdunsisäisen hedelmöitystä estävän laitteen ja sisäänvientilaitteen yhdistelmä
FI973612A7 (fi) Vikavirtavaroke ja sen käyttömenetelmä
FI943729A7 (fi) Kohdunsisäisen hedelmöitymistä ehkäisevän laitteen ja asetinvälineen yhdistelmä
KR960007085U (ko) 콘돔
FIU960163U0 (fi) TV-kondomi ja TV-tamponipolariteetti ehkäisymenetelmätekniikka
KR970060686U (ko) 조루 방지 콘돔
KR970006219A (ko) 셀화된 무기질 바디 및 이의 제조방법
KR960016352U (ko) 콘돔
KR960016351U (ko) 콘돔
KR970020851U (ko) 콘돔
KR960030462U (ko) 콘돔
GB9625483D0 (en) An innovative development of the contraceptive condom
UA1593S (uk) Контрацептив вагінальний

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

MM4A Lapsed by not paying the annual fees

Effective date: 20051104